Identifying and filling public health knowledge gaps in COVID-19 vaccine development has been deemed one of the key network objectives and included as one of the work streams within VACCELERATE.
This work is based on close collaboration with other work streams within VACCELERATE, general public outreach and is anchored in a broad European and international dialogue about new COVID-19 vaccine clinical trials aiming to inform both ongoing and future studies through a living document of priority questions that reflects knowledge gaps and emerging priorities from the public health perspective.
In spring 2021, a stakeholder survey helped us identify a list of emerging and unanswered public health and clinical research questions in relation to vaccine safety, efficacy, vaccination schemes.
Please follow this link to read the full report here.
A total of 89 responses to the stakeholder survey have been received, resulting in 148 submitted priority topics. Responses have been received from 23 countries across the EU but also associated countries via clinical sites registered in the EUVAP platform.
The analysis of the responses has been done internally by RegionH/CHIP as task leader. All the responses have been analyzed thematically and grouped into broader thematic categories resulting in eight thematics and ‘Other’ categories found in the Figure below:
After further categorization, the survey replies have been grouped and compiled into a final list of 17 priority questions that are listed below.